首页> 外文期刊>Radiation Oncology Journal >Comparative Analysis of Patterns of Care Study of Radiotherapy for Esophageal Cancer among Three Countries: South Korea, Japan and the United States
【24h】

Comparative Analysis of Patterns of Care Study of Radiotherapy for Esophageal Cancer among Three Countries: South Korea, Japan and the United States

机译:韩国,日本和美国三个国家食管癌放射治疗护理研究模式的比较分析

获取原文
           

摘要

Purpose: For the first time, a nationwide survey of the Patterns of Care Study (PCS) for the various radiotherapy treatments of esophageal cancer was carried out in South Korea. In order to observe the different parameters, as well as offer a solid cooperative system, we compared the Korean results with those observed in the United States (US) and Japan. Materials and Methods: Two hundreds forty-six esophageal cancer patients from 21 institutions were enrolled in the South Korean study. The patients received radiation theraphy (RT) from 1998 to 1999. In order to compare these results with those from the United States, a published study by Suntharalingam, which included 414 patients [treated by Radiotherapy (RT)] from 59 institutions between 1996 and 1999 was chosen. In order to compare the South Korean with the Japanese data, we choose two different studies. The results published by Gomi were selected as the surgery group, in which 220 esophageal cancer patients were analyzed from 76 facilities. The patients underwent surgery and received RT with or without chemotherapy between 1998 and 2001. The non-surgery group originated from a study by Murakami, in which 385 patients were treated either by RT alone or RT with chemotherapy, but no surgery, between 1999 and 2001. Results: The median age of enrolled patients was highest in the Japanese non-surgery group (71 years old). The gender ratio was approximately 9:1 (male:female) in both the Korean and Japanese studies, whereas females made up 23.1% of the study population in the US study. Adenocarcinoma outnumbered squamous cell carcinoma in the US study, whereas squamous cell carcinoma was more prevalent both the Korean and Japanese studies (Korea 96.3%, Japan 98%). An esophagogram, endoscopy, and chest CT scan were the main modalities of diagnostic evaluation used in all three countries. The US and Japan used the abdominal CT scan more frequently than the abdominal ultrasonography. Radiotherapy alone treatment was most rarely used in the US study (9.5%), compared to the Korean (23.2%) and Japanese (39%) studies. The combination of the three modalities (Surgery+RT+Chemotherapy) was performed least often in Korea (11.8%) compared to the Japanese (49.5%) and US (32.8%) studies. Chemotherapy (89%) and chemotherapy with concurrent chemoradiotherapy (97%) was most frequently used in the US study. Fluorouracil (5-FU) and Cisplatin were the most preferred drug treatments used in all three countries. The median radiation dose was 50.4 Gy in the US study, as compared to 55.8 Gy in the Korean study regardless of whether an operation was performed. However, in Japan, different median doses were delivered for the surgery (48 Gy) and non-surgery groups (60 Gy). Conclusion: Although some aspects of the evaluation of esophageal cancer and its various treatment modalities were heterogeneous among the three countries surveyed, we found no remarkable differences in the RT dose or technique, which includes the number of portals and energy beams.
机译:目的:首次在韩国进行了一项针对食道癌的各种放疗方法的护理模式研究(PCS)的全国性调查。为了观察不同的参数并提供可靠的合作系统,我们将韩国的结果与在美国(US)和日本观察到的结果进行了比较。材料和方法:韩国研究纳入了来自21个机构的246例食道癌患者。患者于1998年至1999年接受放射治疗(RT)。为了将这些结果与美国的结果进行比较,Suntharalingam发表的一项研究对1996年至2006年间来自59个机构的414例患者进行了放射治疗(RT)的治疗。 1999年入选。为了比较韩国和日本的数据,我们选择两个不同的研究。选择五味发表的结果作为手术组,从76个机构中对220例食道癌患者进行了分析。这些患者在1998年至2001年之间接受了手术,接受或不接受化疗的放疗。非手术组源自村上隆的一项研究,其中385例患者在1999年至2004年间接受了仅接受放疗或接受放化疗但无手术治疗。 2001.结果:在日本非手术组(71岁)中,入组患者的中位年龄最高。在韩国和日本的研究中,性别比例约为9:1(男性:女性),而在美国研究中,女性占研究人群的23.1%。在美国的研究中,腺癌的数量超过了鳞状细胞癌,而在韩国和日本的研究中,鳞状细胞癌更为普遍(韩国为96.3%,日本为98%)。食管造影,内窥镜检查和胸部CT扫描是在这三个国家中使用的诊断评估的主要方式。美国和日本使用腹部CT扫描的频率高于腹部超声检查。在美国的研究(9.5%)中,单独使用放射疗法的情况最罕见,相比之下,韩国(23.2%)和日本(39%)研究很少使用放射疗法。与日本(49.5%)和美国(32.8%)的研究相比,在韩国(11.8%)执行这三种方式(手术+放疗+化学疗法)的组合最少。在美国的研究中,化学疗法(89%)和化学疗法同时放化疗(97%)是最常用的。氟尿嘧啶(5-FU)和顺铂是在所有三个国家中使用的最优选的药物治疗方法。在美国研究中,无论是否进行手术,中位放射剂量为50.4 Gy,而在韩国研究中为55.8 Gy。但是,在日本,手术组(48 Gy)和非手术组(60 Gy)的中位数剂量不同。结论:尽管在接受调查的三个国家中,食管癌评估的某些方面及其各种治疗方式不尽相同,但我们发现RT剂量或技术(包括门的数目和能量束)在RT剂量或技术上没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号